MapLight Therapeutics Statistics
Total Valuation
MPLT has a market cap or net worth of $765.28 million. The enterprise value is $462.54 million.
| Market Cap | 765.28M |
| Enterprise Value | 462.54M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MPLT has 55.58 million shares outstanding. The number of shares has increased by 3,972.13% in one year.
| Current Share Class | 52.85M |
| Shares Outstanding | 55.58M |
| Shares Change (YoY) | +3,972.13% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 2.44% |
| Owned by Institutions (%) | 36.27% |
| Float | 20.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.80 |
| P/TBV Ratio | 2.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.52, with a Debt / Equity ratio of 0.01.
| Current Ratio | 16.52 |
| Quick Ratio | 15.79 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -111.55% and return on invested capital (ROIC) is -72.26%.
| Return on Equity (ROE) | -111.55% |
| Return on Assets (ROA) | -67.11% |
| Return on Invested Capital (ROIC) | -72.26% |
| Return on Capital Employed (ROCE) | -69.60% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.73M |
| Employee Count | 133 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 22.13 |
| 200-Day Moving Average | 21.97 |
| Relative Strength Index (RSI) | 43.71 |
| Average Volume (20 Days) | 603,264 |
Short Selling Information
The latest short interest is 3.24 million, so 5.82% of the outstanding shares have been sold short.
| Short Interest | 3.24M |
| Short Previous Month | 3.58M |
| Short % of Shares Out | 5.82% |
| Short % of Float | 15.85% |
| Short Ratio (days to cover) | 2.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -242.93M |
| Pretax Income | -229.83M |
| Net Income | -229.83M |
| EBITDA | -242.34M |
| EBIT | -242.93M |
| Earnings Per Share (EPS) | -$7.42 |
Balance Sheet
The company has $304.73 million in cash and $1.99 million in debt, with a net cash position of $302.74 million or $5.45 per share.
| Cash & Cash Equivalents | 304.73M |
| Total Debt | 1.99M |
| Net Cash | 302.74M |
| Net Cash Per Share | $5.45 |
| Equity (Book Value) | 348.30M |
| Book Value Per Share | 7.67 |
| Working Capital | 299.49M |
Cash Flow
In the last 12 months, operating cash flow was -$174.67 million and capital expenditures -$453,000, giving a free cash flow of -$175.12 million.
| Operating Cash Flow | -174.67M |
| Capital Expenditures | -453,000 |
| Depreciation & Amortization | 585,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -175.12M |
| FCF Per Share | -$3.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MPLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3,972.13% |
| Shareholder Yield | n/a |
| Earnings Yield | -30.03% |
| FCF Yield | -22.88% |
Analyst Forecast
The average price target for MPLT is $26.54, which is 92.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $26.54 |
| Price Target Difference | 92.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |